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ABSTRACT: The self-assembly and biocatalytic activity of the proline-functionalized lipopeptide PRW-NH-C16 are examined
and compared to that of the related PRW−O-C16 lipopeptide, which diﬀers in having an ester linker between the lipid chain and
tripeptide headgroup instead of an amide linker. Lipopeptide PRW-NH-C16 self-assembles into spherical micelles above a
critical aggregation concentration, similar to the behavior of PRW−O-C16 reported previously [B. M. Soares et al. Phys. Chem.
Chem. Phys., 2017, 19, 11811189]. However, PRW-NH-C16 shows an improved catalytic activity in a model aldol reaction. In
addition, we explore the incorporation of the biocatalytic lipopeptide into lipid cubosomes. SAXS shows that increasing
lipopeptide concentration leads to an expansion of the monoolein cubosome lattice spacing and a loss of long-range cubic order
as the lipopeptide is encapsulated in the cubosomes. At higher loadings of lipopeptide, reduced cubosome formation is observed
at the expense of vesicle formation. Our results show that the peptide−lipid chain linker does not inﬂuence self-assembly but
does impart an improved biocatalytic activity. Furthermore, we show that lipopeptides can be incorporated into lipid
cubosomes, leading to restructuring into vesicles at high loadings. These ﬁndings point the way toward the future development
of bioactive lipopeptide assemblies and slow release cubosome-based delivery systems.
KEYWORDS: lipopeptides, peptide amphiphiles, self-assembly, micelles, cubosomes, catalysis, aldol reaction
■ INTRODUCTION
Lipopeptides are versatile molecules, in which peptides are
attached to lipid chains. This can lead to aqueous self-assembly
of the amphiphilic molecules when lipopeptides bear hydro-
philic peptide “headgroups”. Various self-assembled structures
including nanoﬁbers, nanotapes, and micelles, have been
reported.1−6 In the self-assembled lipopeptide nanostructure,
the peptide group is presented at the surface at high density,
often leading to enhanced activity compared to the unlipidated
(and unassembled) peptide.
Proline is an important residue in peptides with catalytic
properties.7−9 Miravet, Escuder, and co-workers have studied a
series of proline peptide gelators, which are eﬃcient catalysts of
the nitro-aldol reaction, among others.10−12 Lipopeptides
simply comprising alkylated proline have been shown to be
eﬃcient catalysts of direct aldol reactions in water and organic
solvents, exhibiting high yields and excellent enantioselectiv-
ities,13 in oil-in-water emulsions.14 In a recent study, a
lipopeptide PRW−O-C16 bearing an N-terminal proline
residue was designed to facilitate biocatalysis via a model
aldol reaction. The peptide incorporates a charged arginine
residue to improve solubility and a tryptophan residue for
ﬂuorescence detection.8 This lipopeptide was shown to self-
assemble into micelles above a critical aggregation concen-
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tration, detected through intrinsic tryptophan ﬂuorescence or
using an added ﬂuorophore probe (pyrene, the ﬂuorescence of
which is sensitive to the hydrophobic environment).8 Because
the ester bond in PRW−O-C16 is susceptible to degradation
(base or enzymatic hydrolysis), in the present work, we
investigate the original peptide in comparison with an analogue
with a peptide (amide) bond, which is expected to have an
enhanced stability. In addition, we explore the incorporation of
the lipopeptide into cubosomes with the intention of
producing high surface area peptide-functionalized nano-
particles. The micellar environment is expected to enhance
the catalytic reaction due to the high density presentation of
proline residues at the surface, where there can also be local
compartmentalization of the reagents.
Cubosomes are stable nanoscale aggregates of lipids forming
bicontinuous cubic phases. They have attracted considerable
attention due to potential application as nanomedicines able to
entrap and subsequently slowly release encapsulated cargo due
to diﬀusion out of the channels in the bicontinuous cubic
structure.15−18 The particles are typically stabilized by
incorporation of small quantities of poly(ethylene oxide)
[PEO]-containing block copolymers such as the Pluronic
PEO−PPO-PEO [PPO: poly(propylene oxide)] poloxamer
triblock copolymers.19,20 The PEO chains form a steric
stabilization barrier around the cubosome nanoparticles.
In the present work, we investigate incorporation of the
lipopeptide PRW-NH-C16 into cubosomes formed by mono-
olein (also known as glyceryl monooleate), which is a model
system for lipid bicontinuous cubic phase formation, forming
Im3m (primitive P or Q229 or “plumbers nightmare” structure)
and Pn3m (“double diamond” or D or Q224 structure) cubic
phases, depending on the concentration in water and the
presence of poloxamers.21−24 Monoolein is also widely used as
the lipid component in cubosomes.16,21,25 We formulate the
cubosomes with the Pluronic F127, often used as a cubosome
stabilizer.16,20,21,25 There are only a few prior studies on
peptide incorporation into cubosomes. The loading of
cubosomes with antimicrobial peptides gramicidin A, alame-
thicin, and mellitin was investigated via small-angle X-ray
scattering (SAXS), with up to 10 mol % incorporated before
disruption of the cubic lattice structure.26 In other studies, slow
release of three other antimicrobial peptides from cubosomes
was conﬁrmed, and the antimicrobial activity was retained or
even enhanced (depending on the antimicrobial peptide and
the bacterium type), while antimicrobial peptide LL37, which
is susceptible to degradation, was stabilized within cubosomes
against proteolysis.27,28 SAXS was used to investigate the
retention of cubic structure within the lipid nanoparticles, and
the eﬀect of peptide loading on this was found to depend on
peptide polarity.27 To our knowledge, incorporation of
lipopeptides into cubosomes has not previously been
investigated, although we hypothesized that this would be a
promising approach to load cubosomes with functionalized
peptides due to the potential ability of the lipopeptide chains
to insert into lipid membranes. Here, in addition to comparing
the self-assembly and aldol catalysis activity of PRW-NH-C16
and PRW−O-C16 (shown in Scheme 1), we also use SAXS to
probe incorporation of the ester-linkage free lipopeptide PRW-
NH-C16 into cubosomes formed by monoolein in the presence
of Pluronic F127. With relevance to potential future
applications of PRW-NH-C16 as a biologically active molecule,
we also examined its cytotoxicity against model ﬁbroblast and
breast cancer cell lines. The cytotoxicity of PRW−O-C16 has
been reported previously.29
■ EXPERIMENTAL SECTION
Materials. Lipopeptide PRW-NH-C16 (Scheme 1) was prepared
by Peptide Synthetics (Peptide Protein Research), Farnham, U.K.,
with purity 99.6% conﬁrmed by HPLC (XB-C18 Kinetex column,
acetonitrile 50%−100% gradient). The molecular mass of PRW-NH-
C16 by ESI-MS is 680.96 g mol
−1 (680.98 g mol−1 expected).
Cubosome Preparation. Cubosomes were prepared with 10 wt
% monoolein (Mo) and 1 wt % Pluronic F127. Mo was obtained from
Sigma-Aldrich (U.K.) while F127 was from a gift from BASF. To
prepare the cubosomes, Mo was melted at 60 °C for 10 min inside an
Eppendorf. After melting, enough 1 wt % F127 solution in water was
added to the Eppendorf, in order to have 10 wt % Mo in the 1 wt %
F127 solution. For cubosomes loaded with PRW-NH-C16, the peptide
powder was added to the melted Mo, and the sample was centrifuged
at 30 000 rpm for 5 min, before the F127 solution was added. The
concentration of lipopeptide was calculated with respect to the weight
of 1 wt % F127 solution. The solution in the Eppendorf was sonicated
with a high intensity ultrasonic probe, using 2 cycles at 30% amplitude
of the maximum power, and 20 s pulses interrupted by 20 s breaks.
Fluorescence Assays. The intrinsic ﬂuorescence of the
tryptophan (Trp) side chain, together with a 8-anilino-1-naphthale-
nesulfonic acid (ANS) assay, were used to locate the critical
aggregation concentration (cac). Spectra were recorded with a Varian
Cary Eclipse ﬂuorescence spectrometer with samples in 4 mm inner
width quartz cuvettes. The ANS ﬂuorophore is a probe sensitive to
the hydrophobicity of its surrounding environment,30 making it
suitable to determine the cac. ANS assays were performed measuring
spectra from 400 to 670 nm (λex = 356 nm), using a 2 × 10
−3 wt %
ANS solution to solubilize the peptide. Trp emission ﬂuorescence was
measured from 350 to 550 nm, using aqueous PRW-NH-C16
solutions, irradiated at λex = 280 nm.
Release of PRW-NH-C16 Loaded into Cubosomes. Release of
lipopeptide was monitored through dialysis. Samples containing 10 wt
% Mo cubosomes were loaded with 0.1, 0.2, or 0.3 wt % PRW-NH-
C16. Aliquots of 20 μL of the solutions containing the lipopeptide-
loaded Mo cubosomes were diluted using 180 μL of water and
injected inside a Slide-A-Lyzer dialysis cassette (10 000 MWCO, 0.1−
0.5 mL capacity; Thermo Fisher Scientiﬁc). Samples were allowed to
dialyze in 60 mL of PBS (Dubelcco, Sigma-Aldrich. The PRW-NH-
C16 release was quantiﬁed by a ﬂuorescamine (FLC) assay, since
primary and secondary amines react with FLC to produce
chromophores (λex = 380 nm, λem ∼ 485 nm). For the FLC assay,
350 μL of sample was withdrawn after 24 h dialysis from the receptor
side and mixed with 150 μL of 0.01 wt % FLC in acetone, just prior to
the ﬂuorescent intensity measurement (excitation at λ= 380 nm). The
Scheme 1. Molecular Structures of PRW-NH-C16 and
PRW−O-C16
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FLC assay was performed using the same cell and instrument
described above for the ANS assay.
Circular Dichroism (CD) Spectroscopy. CD spectra were
recorded using a Chirascan spectropolarimeter (Applied Photo-
physics, U.K.). Solutions were placed in a quartz coverslip cuvette
(0.01 mm thick). Spectra are presented with absorbance A < 2 at any
measured point with a 0.5 nm step, 1 nm bandwidth, and 1 s
collection time per step. The CD signal from the water background
was subtracted from the CD data of the sample solutions.
Fourier Transform Infrared (FTIR) Spectroscopy. Spectra were
recorded using a Nexus-FTIR spectrometer equipped with a DTGS
detector. Samples were measured using a PEARL liquid cell. Spectra
were scanned 128 times over the range of 900−4000 cm−1.
Cryogenic Transmission Electron Microscopy (Cryo-TEM).
Imaging was carried out using a ﬁeld emission cryo-electron
microscope (JEOL JEM-3200FSC), operating at 200 kV. Images
were taken in bright ﬁeld mode and using zero loss energy ﬁltering
(omega type) with a slit width of 20 eV. Micrographs were recorded
using a Gatan Ultrascan 4000 CCD camera. The specimen
temperature was maintained at −187 °C during the imaging. Vitriﬁed
specimens were prepared using an automated FEI Vitrobot device
using Quantifoil 3.5/1 holey carbon copper grids with a hole size of
3.5 μm. Just prior to use, grids were plasma cleaned using a Gatan
Solarus 9500 plasma cleaner and then transferred into the
environmental chamber of a FEI Vitrobot at room temperature and
100% humidity. Thereafter, 3 μL of the sample solution was applied
on the grid and it was blotted twice for 5 s and then vitriﬁed in a 1:1
mixture of liquid ethane and propane at a temperature of −180 °C.
The grids with vitriﬁed sample solution were maintained at liquid
nitrogen temperature and then cryo-transferred to the microscope.
Small-Angle X-ray Scattering (SAXS). SAXS experiments on
solutions were performed using a BioSAXS robot on beamline BM29
(ESRF, Grenoble France) or on beamline B21 (Diamond, Didcot,
U.K.). On ESRF beamline BM29, solutions were loaded into the 96-
well plate of an EMBL BioSAXS robot and then injected via an
automated sample exchanger into a quartz capillary (1.8 mm internal
diameter) in the X-ray beam. The quartz capillary was enclosed in a
vacuum chamber, in order to avoid air scattering. After the sample was
injected in the capillary and reached the X-ray beam, the ﬂow was
stopped during the SAXS data acquisition. BM29 operated with an X-
ray wavelength λ = 1.03 Å (12 keV). The images were captured using
a PILATUS 1 M detector, while data processing was performed using
dedicated beamline software ISPYB. On Diamond beamline B21,
solutions were loaded into the 96-well plate of an EMBL BioSAXS
robot and then injected via an automated sample exchanger into a
quartz capillary (1.8 mm internal diameter) in the X-ray beam. The
quartz capillary was enclosed in a vacuum chamber, in order to avoid
parasitic scattering. After the sample was injected in the capillary and
reached the X-ray beam, the ﬂow was stopped during the SAXS data
acquisition. B21 operated with a ﬁxed camera length (3.9 m) and ﬁxed
energy (12.4 keV). The images were captured using a PILATUS 2 M
detector. Data processing was performed using dedicated beamline
software ScÅtter.
Catalytic Aldol Reaction. The reaction of 109 μL of cyclo-
hexanone (1.1 mmol), 3.0 mg of catalyst (4.4 μmol), and 13.2 mg of
p-nitrobenzaldehyde (93.2 μmol), varying the amount of water (218
μL, 114 μL, no water) was monitored. The solutions were stirred at
room temperature for 2 days. Then the mixtures were extracted with
ethyl acetate four times, via centrifugation at 9000 rpm for 3 min. For
the sample with no water, 0.5 mL of water was added to help in the
extraction step to assist phase separation. The product was monitored
by TLC chromatography, using a mixture 1:4 of ethyl acetate/hexane
as an eluent and vanillin as a developer. After, the samples were kept
on a desiccator under a high vacuum until totally dry, and then NMR
measurements using a (1H) Bruker Ultrashield 300 instrument were
performed at 300 MHz, using deuterated chloroform as a solvent. The
yield and diastereomer anti/syn ratio were calculated using the NMR
spectrum obtained, for which the tetramethylsilane (TMS) was used
as a reference.
Cell Viability Assays. In vitro cell culture was conducted using
MCF-7 (ECACC 86012803), human breast cancer cells, or 161Br
cells (ECACC 90011810), a human skin ﬁbroblast cell line. 161Br
cells were cultured in MEME (minimum essential medium Eagle’s),
with 2 mM glutamine, enriched with 15% fetal bovine serum (FBS),
1% nonessential amino acids (NEAA), and 1% antimicrobial/
antifungal. MCF-7 was cultured with RPMI supplemented with 5%
FBS and 1% antimicrobial/antifungal. All cells were maintained in a
humidiﬁed atmosphere at 37 °C and 5% CO2.
The viability eﬀects of PRW-NH2-C16 was examined using an MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay.
Cells were seeded into a 96-well plate at 4 × 104 cells/mL and allowed
to adhere for 24 h in 100 μL complete medium. After this, peptides
Figure 1. Spectroscopic characterization of PRW-NH-C16 self-assembly in water: cac = 0.04 wt % PRW-NH-C16 is determined from the
concentration dependence of the emission wavelength of tryptophan (a) and the ANS assay (b); (c) CD spectra below and above the cac, (d)
FTIR data above the cac.
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were dissolved in complete medium, and 100 μL of either medium
and/or peptide solution was added, to give either control solution
(complete medium only) or peptide solutions with concentrations in
the range 0.005−0.1 wt %.
Cells were incubated for either 19 or 67 h. Following this, 20 μL
MTT (5 mg/mL, in PBS) was pipetted into each well plate and
allowed to incubate for 5 h (corresponding to a total 24 or 72 h
treatment time, respectively). After this, the solution was removed
from the wells and replaced with 100 μL DMSO per well, in order to
dissolve the formazan crystals. Plates were incubated for 30 min and
then analyzed using a UV microplate reader (λ = 570 nm). Results are
reported as a % cell viability compared to control (untreated) values.
■ RESULTS
Self-Assembly of PRW-NH-C16 Compared to PRW−O-
C16.We ﬁrst measured the critical aggregation concentration of
PRW-NH-C16 via two independent ﬂuorescence probe
methods. Figure 1a shows the concentration dependence of
the intrinsic tryptophan ﬂuorescence peak position (the
original spectra are presented in Figure S1). The onset of
the decrease in peak position indicates the critical aggregation
concentration (cac). Above the cac, the tryptophan ﬂuo-
rescence peak wavelength decreases due to quenching
reduction of the solvent relaxation eﬀect due to the formation
of self-assembled structures, within which this residue is less
exposed to the aqueous environment.31 The cac is determined
to be (0.04 ± 0.01) wt %. This cac also corresponds to a
maximum in ﬂuorescence intensity (Figure S1b) as previously
observed for PRW−O-C16.8 The same cac is determined from
independent measurements using the ANS external ﬂuores-
cence probe, as shown by the discontinuity in the ﬂuorescence
intensity shown in Figure 1b (the original ﬂuorescence spectra
are contained in Figure S2). The cac measured here for PRW-
NH-C16 is the same (within uncertainty) as the value 0.03 wt
% (=0.44 mM) for PRW−O-C16 reported previously.8
The CD spectra in Figure 1c suggest that PRW-NH-C16
adopts a polyproline II (PPII) conformation above and below
the cac,32−34 although there is a shift in position of the positive
maximum from 221 to 226 nm and a change in intensity of the
negative minimum at 198−200 nm. These changes may be
caused by a diﬀerence in the fractional content of peptide with
unordered conformation (disordered conformations are
typically characterized by broad minima near 200 nm and no
maxima32). However, we note that quantitative interpretation
of the CD spectra is complicated by the additional
contribution from electronic transitions of the indole unit in
the tryptophan residue. The amide I’ FTIR spectra in Figure
1d conﬁrm the PPII conformation. A broad band in the 1640−
1645 cm−1 range can be assigned to PPII, although it is diﬃcult
to distinguish this from random coil conformation based on
FTIR.32,35 The spectra are dominated by the peak at 1674
cm−1 due to TFA counterions bound to the arginine
residue.36−38 The presence of this residue also gives rise to
the peaks at 1606 and 1584 cm−1 from arginine side chain
stretching bands.39,40 Peaks due to CH2 stretching modes of
the hexadecyl chains are observed at 2853 and 2926 cm−1
(Figure S3).41,42
Having established that PRW-NH-C16 undergoes aggrega-
tion into a structure in which the peptide retains a PPII
conformation, we used a combination of direct electron
microscopic imaging (cryo-TEM) and small-angle X-ray
scattering (SAXS) to provide detailed information on the
self-assembled nanostructure. Figure 2 shows a representative
cryo-TEM image for a 1 wt % lipopeptide solution and the
SAXS intensity proﬁle for a lipopeptide solution with a ﬁtted
core−shell micelle form factor. The cryo-TEM image shows
the presence of spherical micelle structures with a diameter of
(7 ± 2) nm. This is consistent with the model ﬁt of the SAXS
form factor, which yields an outer radius R1 = (3.41 ± 0.03)
nm and an inner core radius R2 = 1.42 nm. The other ﬁtted
parameters (obtained using the core−shell spherical model I of
SASﬁt software)43 were the relative (electron density) contrast
η = 9.2 × 10−4 and the relative core−shell electron density
ratio μ = −2.47. A ﬂat background BG = 0.6 was also included
in the model. The model indicates a dense core region
comprising the lipid chains surrounded by the less dense
tripeptide corona. Clusters of micelles were noted in some
regions of the TEM grid (as shown for example in Figure S4).
The ﬁnding that PRW-NH-C16 forms spherical micelles is
consistent with the previous results for PRW−O-C16, which
forms slightly smaller micelles with a radius of 3.1 nm.8
Catalytic Activity of PRW-NH-C16 in Aldol Reaction.
To facilitate comparisons, we used the same model aldol
reaction to test the catalytic activity of PRW-NH-C16 as
previously used in tests with PRW−O-C16.8 The reaction
scheme and results (yield and anti/syn stereoselectivity) are
shown in Table 1. Using 5 mol % of PRW-NH-C16 lipopeptide
as a catalyst, the inﬂuence on the conversion factor and
diastereoselectivity of products was observed. Two parameters
were adjusted to inﬂuence the catalytic process: the use of
HFIP (hexaﬂuoro-2-propanol) to dissolve the lipopeptide
before starting the aldol reactions and the water content in the
systems. Considering entries 1 and 2 in Table 1, corresponding
to the presence and absence, respectively, of HFIP, it is clear
that it did not promote any signiﬁcant change in the
conversion and in the aldol product, resulting in both cases
in good levels of anti/syn diastereomeric ratio (93:7), excellent
conversion (>99%), and a high enantiomeric excess (ee) of
89%, as observed in NMR spectra and chiral-phase HPLC
analysis of the anti isomer in Figures S5−S7. These measures
are better than those for PRW−O-C16 under the same
conditions (Table 1).8 On the other hand, considering changes
in the water content, we observed that the absence of water
hinders the formation of the anti-aldol product, producing
lower levels of diastereoselectivity (85:15) and enantiomeric
excess (68%), with only 62% conversion (Entry 4). These
results are similar to those for PRW−O-C16 catalyzing the
same aldol reaction in the absence of water, with 94%
conversion and low diastereoselectivity (86:14), and 73%
enantiomeric excess (Table 1).8 This eﬀect can be associated
with the lower level of organization of the lipopeptide
molecules, due to the absence of hydrophobic interactions in
water that enable self-assembly into micelles. The results are
Figure 2. Self-assembly of PRW-NH-C16. (a) Cryo-TEM image
showing micelles. (b) SAXS data (open symbols) with a model ﬁt
(red line) to the core−shell micelle form factor.
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interesting since they suggest that changes in the supra-
molecular state of the lipopeptide molecules inﬂuence
interactions between the catalyst and the substrate, which
could generate steric hindrance of the reagents, and that the
presence of water is required to enable these reagents to
approach. An additional factor may be the local enhancement
of concentration of reagents near the micelle surface in a
restricted environment where diastereoselectivity of the
reaction could be enhanced.
Incorporation of PRW-NH-C16 into Cubosomes. As a
ﬁrst step toward the investigation of cubosome particle
functionalization with active peptide moieties, we examined
the incorporation of PRW-NH-C16 into model cubosomes.
Although PRW-NH-C16 self-assembles in bulk solution, this
will be modulated within the lipid channels of a cubosome
structure. Lipidation is expected to facilitate insertion of the
lipopeptide into the internal bicontinuous membrane within
the cubosomes. We ﬁrst examined the structure of the
cubosomes with increasing loading of lipopeptide using a
combination of real space imaging (cryo-TEM) and small-
angle X-ray scattering (SAXS). The SAXS data is displayed in
Figure 3, and the cryo-TEM images are shown in Figures 4 and
5. Control SAXS data for the lipopeptide and F127 solutions
are shown in Figure S8, which indicate that F127 is unordered
and the lipopeptide forms micelles as evidenced by SAXS form
factors similar to those shown in Figure 2b. The SAXS data in
Figure 3 contains multiple orders of Bragg reﬂections due to
the bicontinuous cubic structure within the cubosomes. These
were indexed as listed in Table 2 and shown in Figure S9. This
permitted the determination of the lattice constant for the
cubosomes prior to lipopeptide loading, a = (97.2 ± 1.2) Å.
This is within the range of previously reported values (at room
temperature) a = 96.7−97.8 Å44,45 (the temperature depend-
ence of a has also been reported22,46). There is a signiﬁcant
increase in lattice constant with increasing PRW-NH-C16
concentration (Figure 3b), indicating swelling of the aqueous
channels within the cubosomes and/or insertion into the lipid
bilayer. The SAXS data in Figure 3 shows a progressive loss in
the number, and intensity, of reﬂections upon increased PRW-
NH-C16 loading. This indicates a loss of long-range cubic order
within the cubosomes. This was further examined by cryo-
TEM. The images shown in Figure 4 show the high degree of
cubic order within cubosomes prior to addition of lipopeptide,
along with detailed indexation of reﬂections obtained from
Fourier transforms of the images, which in some cases provide
monodomain projections of the cubic structure. The index-
ation is consistent with prior reports on monoolein cubosomes
adopting a Pn3m cubic structure,47,48 but with resolution of
higher order reﬂections. Inspection of lower magniﬁcation
cryo-TEM images such as those shown in Figure 5 indicates a
loss of cubosome content upon an increase in lipopeptide
concentration, this was quantiﬁed by particle counting over
multiple images. As shown in the histogram in Figure 5d, the
number of cubosomes decreases systematically with an
increase in lipopeptide concentration, along with a concom-
itant increase in the number of vesicles. This indicates that
cubosome structure is disrupted by solubilization by PRW-
NH-C16, leading to the formation of vesicles, which may
contain a mixture of monoolein and the lipopeptide or may be
monoolein vesicles stabilized by the presence of the
lipopeptides in solution. That fact that the lipopeptide was
incorporated in the cubosome population was conﬁrmed using
a ﬂuorescamine assay of peptide content in the supernatant
Table 1. Results from the Nitro-Aldol Reaction Test of the Reaction between Cyclohexanone and p-Nitrobenzaldehyde
samples entrya catalyst (mol %) cyclohexanone (equiv) H2O
b (equiv) conversionc (%) anti/sync eed (%)
PRW−NH-C16 1f 5 12.0 2.0 >99 93:7 89
2 5 12.0 2.0 >99 93:7 89
3 5 12.0 1.0 >99 93:7 88
4 5 15.0 e 62 85:15 68
PRW−O-C16 5g 5 12.0 2.0 >99 91:9 84
6g 5 12.0 1.0 >99 91:9 71
7g 5 15.0 e 94 86:14 73
aThe reactions were performed at room temperature, for 2 days, with vigorous stirring. bWater excess toward cyclohexanone (v/v). cThe
diastereomeric ratios and conversion were determine by 1H NMR analysis of the crude mixture. dDetermined by chiral-phase HPLC analysis of the
anti isomer. eNeat (no water addition). fHFIP was not used. gResults presented in ref 8.
Figure 3. (a) SAXS proﬁles for cubosomes made of 10 wt %
monoolein + 1 wt % F127 and loaded with (i) 0, (ii) 0.1, (iii) 0.2, and
(iv) 0.3 wt % PRW-NH−CH16. (b) Dependence of the spacing of the
ﬁrst reﬂection in panel a with the concentration of peptide.
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solution after centrifugation. The spectra in Figure S10 show a
progressive increase in ﬂuorescamine ﬂuorescence with
increasing PRW-NH-C16 concentration, consistent with its
release from the cubosomes at a suﬃciently high lipopeptide
concentration.
Cytotoxicity of PRW-NH-C16. The cytotoxicity of PRW-
NH-C16 was examined using model ﬁbroblast and breast
cancer (MCF-7) cell lines. The cytotoxicity data is displayed in
Figure 6. The assays show that PRW-NH-C16 was rather
cytotoxic to both cell lines, with a signiﬁcant loss of viability
after 24 h (and more at 72 h) at even the lowest lipopeptide
concentration examined (0.005 wt %, which corresponds to
0.05 mg/mL). No signiﬁcant diﬀerence in cytotoxicity was
observed with the ﬁbroblasts or breast cancer cells, so PRW-
NH-C16 does not display selective anticancer activity under
these conditions. These ﬁndings extend the previous
cytotoxicity assay results for PRW−O-C16 (which used a
colon cancer cell model), which only extended over a low
concentration range (up to 0.005 mg/mL).29
■ CONCLUSIONS
Through detailed ﬂuorescence and CD/FTIR assays, we show
that PRW-NH-C16 self-assembles above a critical aggregation
concentration, forming structures with PPII peptide con-
formation. The self-assembled structure above the cac is
spherical micelles. This behavior (and the cac value) is very
similar to that previously reported for the analogue lipopeptide
PRW−O-C16 with an ester linker.8 Thus, the diﬀerent linker
chemistry has very little inﬂuence on self-assembly, indicating
that it does not greatly inﬂuence the amphiphilicity of the
molecule. Indeed, it is likely to be “buried” at the interface
Figure 4. Cryo-TEM images of cubosomes made of 10 wt % monoolein + 1 wt % F127 and loaded with (a−d) 0, (e, f) 0.1, and (g, h) 0.3 wt %
PRW-NH-C16. Scale bars are (a, c, g) 100 or (e) 50 nm. Panels b, d, f, and h are FFT images of panels a, c, e, and g, respectively.
Figure 5. Representative cryo-TEM images of cubosomes made of 10
wt % monoolein + 1 wt % F127 and loaded with (a) 0.1, (b) 0.2, and
(c) 0.3 wt % PRWNH-C16. Scale bars are 100 nm. (d) Counting of
cubosomes vs vesicles as a function of the PRW-NH-C16
concentration, measured from the corresponding cryo-TEM images.
Table 2. Summary of Parameters Extracted from the SAXS
Data in Figure 3 for Cubosomes Containing 10 wt %
Monoolein + 1 wt % F127 and Loaded with 0, 0.1, 0.2, and
0.3 wt % PRW-NH-C16
PRW-NH-C16 (wt %) spacing (Å) indexation
0 108.6 110
77.0 111
62.8 200
48.5 211
44.3
41.0 220
38.5 221/300
36.2 310
32.8 321
0.1 110.9
78.1
63.3
0.2 121.9
84.8
69.1
0.3 128.4
89.9
73.2
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between the hydrophobic lipid chain and the hydrated peptide
headgroup.
We demonstrated that lipopeptide PRW-NH-C16 is able to
eﬀectively catalyze a model aldol reaction, with superior
conversion and enantiomeric excess compared to PRW−O-C16
under comparable reaction conditions.8 Here, the linker group
has an inﬂuence potentially due to the diﬀerences in the local
conformation around the catalytic site and/or the altered
polarization of the amide vs ester linkage. The lower micelle
radius obtained from SAXS data for PRW−O-C16 may reﬂect a
more compact conformation, compared to PRW-NH-C16.
Relevant to potential bionanotechnological applications, the
amide linker should also confer enhanced stability in vivo, due
to reduced hydrolysis.
We additionally show for the ﬁrst time that lipopeptides can
be incorporated within cubosomes, using the model monoolein
cubosome system, stabilized with the Pluronic block
copolymer. A previous report using SAXS to probe the eﬀect
of anionic surfactant-like peptides on the lattice spacing of the
monoolein Pn3m cubic phase (not cubosomes)45 showed,
generally, swelling eﬀects up to deﬁned peptide loadings, at
which concentration the cubic order was lost (replaced by
hexagonal order). In a study of incorporation of antimicrobial
peptides (two neutral and one cationic) into monoolein
cubosomes, little change in lattice spacing was observed in the
Pn3m diamond cubic phase, although signiﬁcant deswelling
was observed for the Im3m primitive cubic phase.26 PRW-NH-
C16 causes an increase in lattice spacing with an increasing
peptide concentration, indicating its incorporation in the cubic
phase. It may either swell the water channel or more likely
incorporate into the lipid bilayer. Interaction with the lipid
bilayer may be enhanced both by favored sequestration of the
lipid chain into the lipid membrane (due to the hydrophobic
eﬀect) but also interaction between the monoolein glycerol
headgroup (hydrogen-bonding capable OH groups) and the
peptide. At high loadings, lipopeptide PRW-NH-C16 causes a
restructuring transition, with a greatly enhanced formation of
vesicles (this is accompanied by an increase in the amount of
lipopeptide in solution, which may be free lipopeptide and/or
lipopeptide self-assembled into micelles). This is a potential
strategy to produce vesicles of monoolein, these structures not
being observed in the equilibrium phase diagram.22,49
Our results show that PRW-NH-C16 is rather cytotoxic to
both ﬁbroblasts and model cancer cells, presumably due to the
strong interaction of the lipopeptide with cell membranes,
which incorporate anionic phospholipid headgroups capable to
bind arginine residues in the PRW peptide, this being in
contrast to the interaction with monoolein, which has a
hydrogen-bonding glycerol headgroup. For future applications,
it should be possible to modulate the interaction of
lipopeptides with diﬀerent types of lipid membrane by the
adjustment of charge and hydrogen-bonding capacity within
the peptide sequence and, in this way, to reduce cytotoxicity.
Indeed, our group and others are investigating the
cytocompatibility of lipopeptides, including examination of
selective anticancer activity (which may be achieved by
conjugation of small-molecule anticancer molecules).50−54
This and other promising bioactivities are attractive subjects
for further research, and cubosomes are potentially valuable
lipopeptide slow release delivery systems. Our initial proof-of-
principle work has established that cubosomes can successfully
be loaded with a model bioactive lipopeptide.
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